| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $41.1M | -18.6% |
| SG&A Expense | $25.7M | -17.0% |
| Income Tax | $0 | — |
| Net Income | -$59.0M | +16.6% |
| EPS (Basic) | -$0.47 | +16.1% |
| EPS (Diluted) | -$0.47 | +16.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | -55.2% |
| Current Assets | $106.0M | -20.2% |
| Total Assets | $191.1M | -21.3% |
| Current Liabilities | $8.0M | +4.2% |
| Total Liabilities | $34.1M | +0.4% |
| Stockholders' Equity | $157.0M | -24.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.7M | +14.3% |
| Capital Expenditures | $1.3M | -39.8% |
| Investing Cash Flow | $35.2M | -46.8% |
| Financing Cash Flow | $214K | -81.3% |
| Free Cash Flow | -$52.0M | +15.2% |